Author:
Daly Megan E.,Monjazeb Arta M.,Kelly Karen
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference74 articles.
1. A placebo-controlled randomized double-blind study of adjuvant intrapleural BCG in patients with resected T1N0, T1N1, or T2N0 squamous cell carcinoma, adenocarcinoma, or large cell carcinoma of the lung. LCSG Protocol 771;Gail;Chest,1994
2. Immunotherapy as an adjuvant to surgery in carcinoma of bronchus. Results in three randomised trials;Roeslin;Eur J Cardiothorac Surg,1989
3. A phase III comparison of radiation therapy with or without recombinant beta-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 93-04);Bradley;Int J Radiat Oncol Biol Phys,2002
4. SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: Phase III results;O'Brien;Ann Oncol,2004
5. Addressing the unmet need in lung cancer: The potential of immuno-oncology;Scagliotti;Cancer Treat Rev,2015
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献